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ABSTRACT  SEC53, a  gene that  is  required  for  completion  of  assembly of  proteins  in  the 
endoplasmic  reticulum  in yeast, has been cloned,  sequenced, and the product localized  by 
cell  fractionation.  Complementation  of a sec53  mutation  is achieved  with unique  plasmids 
from genomic or cDNA expression banks. These inserts contain the authentic  gene, a cloned 
copy of which integrates at the sec53  locus. An open  reading frame in the insert predicts a 
29-kD  protein  with  no  significant  hydrophobic  character.  This prediction  is  confirmed  by 
detection of a 28-kD protein  overproduced in cells that carry SEC53 on a multicopy plasmid. 
To follow Sec53p more directly,  a LacZ-SEC53 gene fusion has been constructed  which allows 
the isolation  of a hybrid  protein  for use in production of antibody.  With  such an antibody, 
quantitative  immune  decoration  has shown that the sec53-6 mutation  decreases the level of 
Sec53p  at  37°C,  while  levels comparable  to  wild-type  are  seen at  24°C.  An  eightfold 
overproduction  of  Sec53p accompanies  transformation  of  cells with  a  multicopy  plasmid 
containing  SEC53. Cell  fractionation,  performed  with conditions  that  preserve the  lumenal 
content  of the  endoplasmic  reticulum  (ER), shows Sec53p highly  enriched  in  the  cytosol 
fraction.  We suggest that Sec53p acts indirectly to facilitate  assembly in the  ER, possibly by 
interacting  with a stable ER component,  or  by  providing  a small molecule,  other than  an 
oligosaccharide  precursor, necessary for the assembly event. 
The secretory pathway in yeast has been defined genetically 
by a series of temperature-sensitive mutant strains blocked at 
various stages in protein transport (1, 2). Class B sec mutants 
(sec53 and sec59) represent the earliest block we have detected 
(3). At the nonpermissive temperature (37"C),  sec53 mutant 
cells accumulate precursors of secreted proteins (such as in- 
vertase) and vacuolar proteins (such as carboxypeptidase Y) 
firmly associated with the endoplasmic reticulum (ER) ~  mem- 
brane (4).  Although mutant cells accumulate full-length in- 
vertase polypeptide at 37"C,  normal core glycosylation and 
folding to an enzymatically active configuration are blocked. 
On  return  to  a  permissive  temperature  (24"C),  precursor 
invertase  is  glycosylated,  restored  to  an  active  form,  and 
secreted. Hence, the sec53 block may represent an authentic 
intermediate step in the process of assembly in the ER. These 
characteristics are unlike the phenotype expected for muta- 
l Abbreviations used in this paper:  ER, endoplasmic reticulum; PCI, 
phenol/chloroform/isoamyl alcohol (25:24:1); TBS, Tris-buffered sa- 
line (50 rnM Tris-HC1, pH 8.0,  150 mM NaC1). 
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tions in subunits of the signal recognition particle or docking 
protein, which would result in accumulation of truncated or 
complete secretory polypeptides in the cytoplasm. 
On the basis of these and other results, we proposed that 
the SEC53 gene product acts directly to facilitate the complete 
penetration of polypeptides into the ER lumen. According to 
this view, the SEC53 gene product (Sec53p) would either be 
an integral component of the ER membrane, or peripherally 
associated on the lumenal surface of the membrane. To test 
this hypothesis, we have identified Sec53p by the application 
of molecular cloning techniques. In contrast to our expecta- 
tion, we report here that Sec53p is a hydrophilic, cytoplasmic 
protein. 
MATERIALS AND  METHODS 
Strains, Plasmids, Growth Conditions, and Materials:  The 
bacterial and yeast strains used in this study are listed in Table I. 
Escherichia  coli plasmids pUC9  and  pUR290,  used  to  make  carboxyl 
terminal fusions to ~-galactosidase, have been described by others (7, 8). The 
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Strain  Genotype  Source or reference 
S. cerevisiae 
X2180-1 B  MATa gal2-  YGSC* 
MBY7-5C  MATa sec53-6 trpl-289 leu2-3,112 ura3-52 his-  This study 
MBY21  MATa/MATa  SECS3/sec53-6 CAN1/canl  trpl-289/trpl-289  leu2-3,112fleu2-3,112  This study 
ura3-52/ura3-52 his-lhis- 
MAT~ sec 18- I 
MATc~ trpl-289 leu2-3,112 ura3-52 his3- his4- 
HMSF 176 
JRY9 
E. coil 
MC 1061 
MC 1061 [chr::Tn5] 
BMH 71-18 
F- araD139 A(araABOIC-leu)7679 Alacx74 galU galK rpsL hsdR 
MC 1061  containing a chromosomal rn5 insertion 
A(lac pro) F' laclqZAM15 pro  + 
reference 1 
J. Rine 
reference 5 
R. Foster and J. Rine 
reference 6 
* Yeast Genetic Stock Center, University of California,  Berkeley, California. 
pSEC  5310 
/  H  / 
./1 / 
® 
2~.C~~  ~  pBR322 
/ 
/  EHE  ~  B EK  B  P  H PE 
SEC53 
< 
E. co~i-yeast shuttle  plasmid  YEpI3 (9) contains  the yeast LEU2 gene and 
sequences  needed  for autonomous replication  in  both hosts.  YIp5  (10), an 
integrating  plasmid,  contains  the  yeast URA3 gene but lacks a sequence for 
replication  in yeast. The yeast genomic  DNA library,  constructed  by K. A. 
Nasmyth, contains DNA fragments  obtained  by a  partial  Sau3A  restriction 
enzyme digest inserted into YEpI3 (l l). The yeast cDNA expression library of 
McKnight and McConaughy contains inserts adjacent to the ADHI promoter 
on a plasmid that also carries the yeast TRPI gene (12). 
YPD medium contained  1%  Bacto-Yeast extract,  2%  Bactopeptone,  and 
varying amounts of glucose. Wickerham's minimal medium (13) was used with 
5% glucose as a carbon source. For 3sSO42- labeling of cells, sulfate salts were 
replaced  by chloride  salts and ammonium sulfate was added  to the desired 
concentration.  The absorbance of dilute cell suspensions was measured in a l- 
cm cuvette at 600 nm in a Zeiss PMQII spectrophotometer,  10D~oo unit of 
cells corresponds to 0.15 mg dry weight. 
Other reagents  were obtained  as indicated:  ATP,  GTP,  deoxynucleoside 
triphosphates,  NAD  ÷,  NADH, cytochrome  c,  O-nitrophenyl-#-D-galactopyr- 
anoside,  acetylphenythydrazine,  hemin (type  I, bovine),  phosphocreatine,  ~- 
aminocaproic  acid,  creatine  phosphokinase  (type  I),  micrococcal  nuclease, 
spermidine  (free base), diethyl  pyrocarbonate,  bovine  serum albumin (BSA) 
(radioimmunoassay  grade),  protein  A,  isopropyl-thio-#-D-galactoside,  and 
Freund's complete and incomplete adjuvant were obtained from Sigma Chem- 
ical  Co.  (St. Louis,  MO);  restriction  endonucleases  and DNA modification 
enzymes were from Bethesda Research Laboratories  (Gaithersburg,  MD); di- 
deoxynucleoside triphosphates were from P-L Biochemicals (Milwaukee, WI); 
glyceraldehyde-3-phosphate (diethylaeetal form) and calf liver tRNA were from 
Boehringer  Mannheim Biochemicals (Indianapolis,  IN); H235SO4 (1,255 Ci/ 
mmol), [35S]methionine  (1,200 Ci/mmol), and t25I-Na (highest specific activity) 
were from Amersham Corp. (Arlington Heights, IL); nitrocellulose was from 
Schleicher & Schuell, Inc.,  Keene,  NH); RNAsin  was from Promega  Biotec 
(Madison, WI); Oligo dT cellulose was from Collaborative Research (Waltham, 
FIGURE  1  Restriction map of plasmid pSEC5310. 
(a) pSEC5310 contains a 7-kb insert in YEp13 that 
complements sec53 cells.  The  heavy arrow indi- 
cates the direction and approximate limits of the 
SEC53 mRNA, as determined from a cDNA clone. 
(b) Fragments from pSEC5310 that are subcloned 
into  different  vectors  referred  to  in  the  text.  E, 
EcoRI; K, Kpnl; B, Bglll; H, Hindlll; P, Pstl. 
lkb  > 
MA); DEAE cellulose (DE-52) was from Whatman Ltd.  (Maidstone,  Kent, 
UK); IgG Sorb was from The Enzyme Center (Boston, MA); EN3HANCE was 
from New England Nuclear  (Boston, MA). Lyticase and anti-invertase  anti- 
serum were prepared as described before (14, 15). Protein A was labeled with 
~25I by the chloroamine  T/NaI method (16). 
Cloning,  Sequence  Analysis,  and  Transposon-mediated 
Mutagenesis of SEC53:  Yeast strain MBY7-SC was grown in YPD (5% 
glucose) medium to an OD~o of 1-2 and converted to spheroplasts which were 
transformed  with the genomic DNA library of Nasmyth (see reference  I l) or 
the cDNA library of McKnight  and McConaughy  (12). Transformants were 
selected on minimal  medium lacking an amino acid (leucine for the genomic 
library; tryptophan for the cDNA library) at 24"C. After 24 h, at which time 
transformants  began  to appear,  plates were transferred  to the sec restrictive 
temperature  (37"(2). Colonies that continued  to grow were selected, replated, 
and plasmid DNA was isolated from each. Yeast plasmid DNA was used to 
transform E. coil strain MCI061.  Plasmid DNA was isolated from individual 
transformants  and complementation  of  both sec53 and amino acid auxotrophy 
was confirmed by transformation  of the original yeast host. 
Plasmid pSEC5310 was isolated from the genomic DNA bank and contains 
a 7-kb insert  in YEpl3 that includes the SEC53  gene (Fig. la). pSEC5315 
contains a 1. l-kb Bglll fragment (Fig. 1  b, fragment A) that includes SEC53 in 
YlpS.  pSEC5319  contains  the  0.4-kb  EcoRI  fragment  of SEC53  (Fig.  I b, 
fragment B) subcloned into YIpS. pSEC5316 contains the 5' half of SEC53 
(Fig. 1  b, fragment C) subcloned into pUC9. 
Restriction  endonuclease  digestions  and  T4  DNA  ligase reactions  were 
carried out according to the supplier's  instructions.  Reactions with ]'4 DNA 
polymerase  were performed  as described  by Maniatis  et al.  (17). Standard 
techniques of plasmid isolation, agarose gel electrophoresis, and DNA transfor- 
mations of E. coli and S. cerevisiae have been described elsewhere (17-19). 
DNA sequencing was performed using the dideoxy chain termination  method 
BERNSTEIN ET AL.  Characterization  of the SEC53  Gene  Product  2375 of Sanger et al. (20).  M 13 primer was a gift of W.  Rottman and E.  Penhoet 
(Department of Biochemistry, University of California at Berkeley). 
Transposon-mediated mutagenesis of  SEC53 was performed in E. cull strain 
MC 1061 [chr::Tn5] transformed with pSEC5310. Cells were selected on ampi- 
cillin-containing  plates and 24 separate resistant transformants were grown to 
stationary phase in 6-ml L broth cultures. Plasmid preparations from each were 
suspended in 0.03 ml of 10 mM Tris-HCl, pH 7.6, 2 mM EDTA, and 0.01 ml 
of each was used to transform strain MCI061. Cells containing plasmids that 
sustained a transposition event were selected on LB plates containing ampicillin 
(100 #g/ml) and Kanamycin (25 ug/ml). Out of l0  s ampicillin-resistant  trans- 
formants, from 0 to 14 were doubly resistant. One amp' kan' colony from each 
transformation was used to prepare plasmid, which was used to retransform 
MC1061  to  insure that  the drug resistance phenotype was plasmid linked. 
Eleven independent Tn5 insertions into pSEC5310 were obtained. 
RNA Preparation  and In Vitro  Translation:  RNA was isolated 
from  strain X2180-1B.  Cells (-2,000  OD~o  units) were sedimented, resus- 
pended  in 40  ml of water,  distributed into  10-ml aliquots, and centrifuged 
again. Cell pellets were resuspended in 3 ml each of Buffer A (0.2 M Tris-HCl, 
pH  7.5,  0.5 M  NaCI, 0.01  M  EDTA,  1% SDS).  Glass beads (0.5  mm) were 
added to -3/4 of the final volume, followed by 3 ml of PCl (phenol/chloroform/ 
isoamyl alcohol; 25:24:1). Samples were agitated on a vortex mixer for 2 min 
at room temperature, pooled into two samples, and each diluted with 6 ml of 
water. After mixing, samples were centrifuged at 8,000 g for 10 min in a Sorvall 
HB-4 rotor at 24"C. The aqueous layer was removed and re-extracted with PCI, 
and the organic layer was re-extracted with 5 ml of water. After centrifugation, 
the aqueous layers were pooled, and the PCI extraction was repeated four to 
five times until the interface was free of particulate material. Nucleic acid was 
precipitated with ethanol, sedimented, resuspended in water, and precipitated 
again prior to use. Approximately 30 mg of nucleic acid were obtained in this 
preparation. Aqueous solutions were treated with 0.01% diethylpyrocarbonate 
and autoclaved prior to use. 
Hybrid selection from total yeast RNA was performed as described elsewhere 
(21).  Nitrocellulose filters containing plasmid DNA  were exposed to  RNA 
individually  with one filter per container. 
Rabbit reticulocyte lysates were prepared  by the method  of Pelham and 
Jackson (22), as modified by Appling and Rabinowitz (23). Translation reac- 
tions contained 100 mM potassium acetate, 0.8 mM magnesium acetate, and 
other components as described (23). After incubation for 60 rain at 30"C, one- 
tenth (3 #1) of each sample was removed, mixed with 17 #1 of SDS gel sample 
buffer, and heated in boiling water for 3 rain. The remainder of the translation 
mix was prepared for immune precipitation by addition of SDS to 2%, followed 
by heating as above. Samples were diluted 30-fold in phosphate-buffered saline 
(PBS) (12.5 mM sodium phosphate, pH 7.5, 0.2 M NaCI) +  I% Triton X-100 
and incubated with 0.1 ml oflgG Sorb at 0*C for 15 min. A clarified supernatant 
fraction, obtained by centrifugation for 2 min in a microfuge, was split in half 
and mixed with antibody. For immune serum, precipitations contained 0.02 
ml of an IgG fraction (6.5 mg protein/ml); preimmune controls contained 0.01 
ml  of crude serum.  Samples were  incubated overnight at 0*C  followed by 
addition of 75 ~1 of IgG Sorb. Immune complexes were washed as before (15). 
Final pellets were resuspended in 0.04 ml of SDS gel sample buffer and heated 
as before. Clarified supernatant fractions were analyzed by SDS gel electropho- 
resis on  12.5% polyacrylamide gels as described by Laemmli (24). Gels were 
fixed, treated with EN3HANCE, and radioactive proteins localized by exposure 
to Kodak X-OMAT AR Film at -70"C. 
Sec53p Antiserum:  The 0.4-kb EcoRl fragment from pSEC5310 (Fig. 
l b, fragment B) was isolated and converted to a fully duplex form by treatment 
with T4  DNA  polymerase and the four deoxynucleoside triphosphates. This 
fragment was inserted by blunt end Iigation into vector oUR290 that had been 
converted  to  a  linear completely duplex  form  by treatment  with BamHl 
endonuclease and T4 DNA polymerase plus deoxynucleoside triphosphates. E 
coil  BMH71-18  was  transformed  with  the  ligated sample  and  ampicillin- 
resistant colonies were selected. Plasmids from individual transformants were 
isolated and  evaluated by  restriction analysis for  insertion  of the  SEC53 
fragment. Promising transformants were further screened for production of a 
protein of the size expected for the #-galactosidase-Sec53p hybrid (-135 kD). 
A plasmid (pSCZ5350) that satisfied these criteria was isolated and the LacZ/ 
SEC53 DNA junction was sequenced to confirm that fragment B  had been 
inserted  in  the  proper  orientation  and  reading  frame.  The  fusion  protein 
retained B-galactosidase activity. 
To purify the hybrid protein, BMH71-18/pSCZ5350 was grown at 37"C in 
LB/amp medium (2L) to an OD~4o of -0.5 isopropyl-thio-#-D-galactoside  was 
added to a  final concentration of 1 mM and incubation continued for 65-75 
min. Cells were centrifuged at 4"C and broken  as described elsewhere (25). 
After a brief sonication, cell extracts were centrifuged for 1 h at 100,000 g in a 
Beckman Type 40 rotor at 4"C. Over 75% of the #-galactosidase activity was 
in the 100,000-g pellet fraction. The sediment was suspended in 5 ml of 0.02% 
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SDS and centrifuged for 20 min at 39,000 g  in a Sorvall SS-34 rotor at 4°C. 
About 50% of the total #-galactosidase activity was recovered in the final pellet 
fraction which represents between 10 and 15 mg of hybrid protein. This material 
was resuspended in 7 ml of SDS gel sample buffer and heated for 5 min in a 
boiling water bath. Solubilized samples were applied to preparative SDS gels 
made  of  5%  polyacrylamide. After  electrophoresis, gels were  stained  with 
Coomassie Blue and the hybrid protein band was cut from the gel. Gel pieces 
were suspended in SDS stacking gel buffer, and protein was electroeluted into 
dialysis tubing.  Eluted  protein  was dialyzed extensively against water and 
lyophilized. 
Rabbits were immunized by multiple intradermal injections (26).  Primary 
injections contained -200 #g of hybrid protein in Freund's complete adjuvant. 
The same amount of protein in Freund's incomplete adjuvant was used in 
boosts. After two boosts, blood samples were collected and fresh boosts given 
at intervals of 7 to 10 days. Crude serum was used directly or after isolation of 
the  IgG  fraction by the  DEAE cellulose method  (26).  Two  rabbits gave a 
significant immune response after five boosts. 
Cell fractionation and Detection of Sec53p:  For detection of 
metabolically radiolabeled Sec53p, yeast strain MBY7-5C, containing different 
plasmids, was grown  at  24"C to  an  OD~o  of 0.5-1.5  in  minimal medium 
containing 0.1  mM ammonium sulfate. Aliquots (0.50D~o unit of cells) were 
centrifuged and cells resuspended in 2 ml of minimal medium containing 0.05 
mM ammonium sulfate. H235504 (0.25 mCi) was added and incubation con- 
tinued for 6  h  at 24"C.  Labeled cells were centrifuged at room temperature, 
washed once with 5 ml cold 10 mM NAN3, and resuspended in 0.1  ml of SDS 
gel sample buffer. Proteins were extracted by heating for 5  min in a  boiling 
water bath. Debris was removed by sedimentation in a  microfuge for 5  min 
and samples of the supernatant fraction (3  x  106 cpm/lane) applied to SDS 
gels containing 12.5 % polyacrylamide. After electrophoresis, gels were exposed 
to X-ray film as above. 
For immune detection of Sec53p in unfractionated extracts, strain MBY7- 
5C containing different plasmids was grown to an ODec~ of 0.5-2.5 in minimal 
medium containing 0.2 mM ammonium sulfate. Cells (10 ODs0o units) were 
sedimented, washed once with cold  l0 mM NAN3, and resuspended in 0. l  ml 
of 2%  SDS,  1 mM phenylmethylsulfonyl fluoride. Glass beads (0.3  g) were 
added and samples agitated at full speed for 2 min on a vortex mixer, followed 
by heating for 3 min in boiling water. The extract solution was removed and 
the glass beads washed three times with 0.05 ml of 0.1% SDS. Pooled extracts 
contained between 1.5 and 3.4 mg protein/ml. 
Subcellular localization was performed on a  secl8 mutant strain to allow 
detection  of  Sec53p  and  ER-localized  invertase  in  the  same  fractions. 
HMSF176a was grown at 24"C to an ODr0o -2 in YPD with 5% glucose. Two 
aliquots (300 OD~o  units cells each) were centrifuged and cells were resus- 
pended in 150 ml YPD with 0. 1% glucose (conditions which derepress synthesis 
of invertasc); one sample was incubated at 24"C, the other at 37°C.  After 40 
min, NaN3 was added to  l0 mM, and cells were sedimented and resuspended 
in  10 ml of l0 mM Tris-SO42--,  pH 9.4, 30 mM 2-mercaptoethanol,  l0 mM 
NAN3. Samples were incubated for  l0 min at room temperature, centrifuged, 
and washed once with l0 mM NAN3. Cell pellets were resuspended in 3  ml 
spheroplast buffer (1.5 M sorbitol, 50 mM Tris-HCl, pH 7.2,  2 mM MgCI2,  l0 
mM NAN3), lyticase was added to 20 units/ODt~ unit of cells, and cells were 
converted to  spheroplasts during a  30-min  incubation at  30*C  with gentle 
agitation. This solution was layered on a  cushion of spheroplast buffer that 
contained 1.8 M  sorbitol, and spheroplasts were sedimented at 8,000 g  for 5 
min at 4"C in a Sorvall HB-4 rotor. The pellet was resuspended in  1.5 ml of 
Buffer  B  (0.3  M  mannitol,  0.1  M  KCI,  20  mM  2,  (N-morpholino)ethane 
sulfonic acid, pH  6.5,  5  mM  MgCI2,  1  mM  EGTA,  1 mM  NAN3,  l  mM 
phenylmethylsulfonyi fluoride) and glass beads were added to 3/4 of the final 
volume. Lysis was achieved by three  15-s agitations on a VWR vortex mixer 
(setting 3).  Liquid was removed and the glass beads were washed five times 
with 0.75 ml Buffer B. Solutions from the same lysate were pooled and adjusted 
to 5 ml with Buffer B. An aliquot ( 1 ml) of the extract was removed, and the 
remainder centrifuged at 660 g for 3 min at 4°C in a Sorvall HB-4 rotor. 3 ml 
of the supernatant fraction was removed and centrifuged at 100,000 g for 1 h 
at 4"C in a  Beckman type 40 rotor (Beckman Instruments, Inc., Pulp Alto, 
CA).  The  high speed supernatant fraction was removed, and the pellet was 
gently washed with Buffer B and resuspended in Buffer B +  0.1% Triton X- 
100. 
Immunoblotting was used to quantify the subcellular distribution of Sec53p 
and  of the  cytoplasmic and  ER-accumulated forms  of invertase.  Fractions 
subjected to SDS gel electrophoresis were transferred to nitrocellulose filters 
(27), which were then blocked in Tris-buffered saline (TBS) (50 mM Tris-HCl, 
pH 8.0,  150 mM NaCI) with 1% BSA. Antibody reactions were also performed 
in the buffer. After exposure to antibody, filters were washed for 10 min each 
in TBS,TBS + 0.4% Triton X-100 + 0.05% SDS, and TBS. Washed filters were 
treated with 12~l-labeled protein A (2.5  x  104 cpm/ml, 5 x  106 cpm/ug protein) (27). Filters were again washed sequentially and reactive proteins visualized by 
autoradiography  using an intensifying screen at -70"C. Autoradiograms  were 
quantified  by  scanning  with  a  Kratos  model  SD3000  spectrodensitometer 
coupled to a Kratos SDS300 density computer (Kratos Analytical Instruments, 
Ramsey,  N  J) and  Hewlett-Packard  3380A integrator  (Hewlett-Packard  Co., 
Palo Alto, CA). 
Assays and Other Procedures:  NADPH cytochrome  c reductasc 
was assayed as described by Kubota et at. (28). Glyceraldehyde-3-phosphate 
dehydrogenase was assayed as described elsewhere (29). The diethylacelal form 
was converted  to glyceraldehyde-3-phosphate  by heating  a  10-raM solution 
containing  0.1 g/ml Amberlite IR120 (H  ÷ form) for 2 rain in a boiling water 
bath.  After filtration,  aliquots  were stored  frozen at -20"C.  B-Galactosidase 
activity was measured at described by Miller (30). Protein was measured by a 
modification of the Lowry procedure (31). 
RESULTS 
Cloning and Sequence Analysis of SEC53 
Yeast strain MBY7-5C was transformed separately with a 
yeast genomic DNA library and a cDNA library. Transform- 
ants were selected simultaneously for growth on a  medium 
minus the relevant amino acid and for growth at 37"C,  the 
restrictive  temperature  for sec53  cells.  From  the  genomic 
library, -15,000  Leu  + colonies were obtained,  of which 75 
were  also  Ts  +.  The  cDNA  library  yielded  ~15,000  Trp  + 
transformants of which ~30 were also Ts  +. 
Plasmids  that  conferred  a  Ts  + phenotype were  isolated, 
used to transform E. coli, and re-isolated. Individual plasmids 
were then used to transform yeast to confirm that the initial 
Ts  + and prototrophic phenotypes were plasmid linked. Eight 
complementing plasmids (four each from the genomic and 
cDNA  libraries) were  analyzed by restriction  mapping;  all 
contained DNA from the same genomic region. A restriction 
map of one genomic clone that complements sec53 muta- 
tions, pSEC5310, is shown in Fig.  1 a. The direction of tran- 
scription  and  approximate limits of the  SEC53  gene  were 
determined by comparing the restriction map of pSEC5310 
with a cDNA clone that also conferred a Ts  + phenotype to a 
sec5  3 strain. 
Genetic analysis was used to prove that plasmid pSEC5310 
contains the structural gene for sec53.  Fragment A (Fig.  1  b), 
a  1,700  BgllI restriction fragment that complements see53, 2 
was subcloned into the yeast integrating plasmid YIp5, form- 
ing pSEC5315.  This construct was used to transform strain 
MBY7-5C, and stable Ura+/Ts  + transformants were selected. 
A transformant was crossed to another ura3-52, sec53-6 strain 
to form a  diploid cell,  which was then sporulated and sub- 
jected to tetrad analysis. The Ura+:Ura  -  and Ts+:Ts  - pheno- 
types  showed  2:2  segregation  patterns  as  expected  if 
pSEC5315 had integrated into the genome at a single site. In 
addition,  analysis  of 29  asci,  each  containing  four  viable 
spores,  showed  that  the  Ura+/Ts  + phenotypes were tightly 
linked with a genetic distance of_< 1 cM. When the Ura+/Ts  + 
transformant was crossed with  a  URA3,  SEC53  strain,  all 
progeny spores of  20 tetrads were Ts  +, proving that integration 
had occurred at the SEC53  locus. Though both parents in 
this cross were Ura  +, approximately one-fourth of  the progeny 
were Ura-, consistent with integration ofpSEC5315 at a locus 
distinct from URA3. 
The conditional lethality of sec53 mutations is consistent 
with either a  thermosensitive sec53 product, or with a  null 
2 Fragment A contains only 35 bp upstream from the first nucleotide 
identified in  the  cDNA insert.  This fragment  complements  see53 
when present on a multicopy plasmid; consequently, some promoter 
function may be provided by vector sequences. 
mutation that exposes an independent thermosensitive proc- 
ess. These possibilities were distinguished by disruption of the 
SEC53 chromosomal locus in a diploid cell, followed by tetrad 
analysis.  The  0.4-kb  EcoRl  fragment of SEC53  (Fig.  1 b, 
fragment B) was subcloned into YIp5 (pSEC5319) and cut at 
the unique KpnI  site within SEC53 to direct integration at 
the SEC53  locus (32).  Linear DNA was used to transform 
diploid strain MBY21  and stable Ura  + transformants were 
selected. Plasmid integrations at the wild-type locus (12 Ura+/ 
Ts- transformants) and  sec53-6  locus  (20  Ura+/Ts  + trans- 
formants) were obtained. Transformants that had integrated 
pSEC5319 at the sec53 locus were sporulated and only asci 
with two viable spores (24 total) or one viable spore (8 total) 
were recovered. Ths spores were all Ura-/Ts  +,  while other 
loci (MATa/MATc~  and  CAN1/canl)  were  unaffected and 
assorted independently of the lethal phenotype. From these 
results we conclude that disruption of the SEC53 locus is a 
lethal event and that this gene is required for spore germina- 
tion. 
The DNA sequence of the SEC53 gene, shown in Fig. 2 a, 
contains a single long open reading frame, uninterrupted by 
introns, starting at the nucleotide designated + 1 and termi- 
nating with an amber codon after nucleotide 762.  This open 
reading  frame  predicts  a  hydrophilic  polypeptide  of  254 
amino acids (30% charged) with a molecular weight of 29,050. 
Hydropathic  analysis,  based  on  the  program of Kyte and 
Doolittle (33), shows no hydrophobic region long enough to 
span  a  lipid bilayer.  No  significant  sequence  homology to 
proteins in the Dayhoff protein sequence bank at the Univer- 
sity of California, San Francisco, was found for the SEC53 
coding region. 
Examination of the DNA sequence upstream from SEC53 
reveals TATA sequences, which are thought to be involved 
in positioning the start of transcription (34), centered around 
positions  -13,  -85,  and  -162.  The  first  SEC53  nucleotide 
identifiable in our cDNA clone is at position -47, thus the 
TATA sequences around nucleotides -85  or -162 may func- 
tion in vivo. Also highlighted in Fig.  2 a  are sequences that 
may be involved in transcription termination and polyaden- 
ylation.  The  sequence  TAG  ......  16  nucleotides  ..... 
TACGT .....  10 nucleotides .... AAA, located between nu- 
cleotides 763-800 (80 nucleotides upstream of the poly A site 
found in our cDNA insert), is homologous to a  conserved 
sequence that may function in termination and polyadenyla- 
tion  of yeast mRNAs (35).  Another  sequence,  AAUAAA, 
thought to function in polyadenylation of eukaryotic mRNAs 
(36), is found 38 nucleotides upstream from the eDNA poly 
A site. 
Detection of Sec53p 
To  identify  directly  the  SEC53  gene  product  (Sec53p), 
strain MBY7-5C containing pSEC5310,  YEpI3, or no plas- 
mid, was labeled for 6 h with 35SO2-.  Labeled proteins were 
extracted and evaluated by SDS gel electrophoresis and au- 
toradiography. A species of ~28-kD was overproduced in cells 
transformed with the multicopy SEC53 plasmid (Fig. 3, lane 
B), as compared with control cells. The size of  this polypeptide 
is  consistent  with  the  molecular  weight  predicted  for  the 
SEC53 gene product. Detection of Sec53p by this technique 
indicates that this protein is abundant.  This correlates with 
the level of SEC53 mRNA, which was shown by Northern 
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Bgl  II 
AAATTT~~T~T~`~GTTTTTTAC~TGTT~TTTTCA~TTATTTTTCTGTTTATATC~TCTA~TCTTCTTG~CAAA~-~-~ATCTTTGAC CAA  -70 
i  Eco RI 
AACTAAAT~A~AATTT~TTAGTACTT~TTTCT~CTTTTTTACCTATCT~~CACCAATAAT~A~TATCGCT~AATTC~CTTACAA~AAAAACCA  36 
M  S  I  A  E  F  A  Y  K  E  K  P  12 
•AAACTTT•GTTTTATT••AT•TT•AT•GTACCTT•ACACCAGCCA•ATTAACTGTTTCTGAA•AA•TTA•AAAAACTTT•GC•AA•TTGA•AAACAA•TG•TCC  ~.41 
E  T  L  V  L  F  D  V  D  G  T  L  T  P  A  R  L  T  V  S  E  E  V  R  K  T  L  A  K  L  R  N  K  C  C  47 
ATT••TTTTGTCG•T••TTCTGACTTAA•CAAGCAATTA•AACAGTTA•GCCCAAACGTTTTA•ATGAATTT•ACTATTCTTTCTCTGAAAAT•GTTTGACCGCC  246 
I  G  F  V  C  G  S  D  L  S  K  Q  L  E  Q  L  G  P  N  V  L  D  E  F  D  Y  S  F  S  E  N  G  L  T  A  82 
TACA~ATTAGGTAAGGAATTA~CTTCT~AATCCTTCATCAACTG~CTCGGTGA~AAA~TACAATAAATTG~CCGTCTTCATTTT~AGATATCTATCTGAAATT  351 
Y  R  L  C  K  E  L  A  S  Q  S  F  I  N  W  L  C  E  E  K  Y  N  K  L  A  V  F  I  L  R  Y  L  S  E  I  117 
EcoRI 
GACTTGCCAAAGAGAA•A•GTACTTTCTT••AATTTAGAAAT•GTATGATCAAC•TTTCCCCAATTGGTA•AAAT•CTTCTACT•A•GAAAGAAAC•AATTC•AA  456 
D  L  P  K  R  R  G  T  F  L  E  F  R  N  G  M  1  N  V  S  P  I  G  R  N  A  S  T  E  E  R  N  E  F  E  152 
Hindlll  Eco  RI 
AGATAC•ATAA••AACACCAAATCAGAGCCAA•TTC•TTGAAGCTTTGAAAAAGGAATTCCCAGACTACG•TTT•ACTTTCTCCATTGGTGGCCAAATCTCTTTC  561 
R  Y  D  K  E  H  Q  I  R  A  K  F  V  E  A  L  K  K  E  F  P  D  Y  G  L  T  F  S  I  G  G  Q  I  S  F  187 
•AC•TTTTCCCC•CT••TTGGGATAA•ACCTACTGTTTGCAACACGTTGAAAAAGATGGTTTCAA•GAAATTCATTTCTTTG•T•ACAAGACTAT••TC••TGGT  666 
D  V  F  P  A  G  W  0  K  T  ¥  C  L  q  H  V  E  K  D  C  F  K  E  I  11  F  F  G  D  K  T  M  V  G  C  222 
AAC•ATTACGAAATTTTT•TC•ATGAAA•AACCATCGGACATTCAGTACAATC•CCTGATGACACCGTCAAAATTTTGACTGAACTATTCAACTTATA•CTTTAT  77 1 
N  D  Y  E  I  F  V  D  E  R  T  I  G  II  S  V  Q  S  P  D  D  T  V  K  I  L  T  E  L  F  N  L  254 
TTCCAG~TT~CT&CGT~ATTATGCCATTTGT~ATCCGTTTG~TGATTCTTTTTTATCCTTCTTATAT.~g~ATACTCTTACTAC~TTATTGAATGTGTACT  876 
~  I  I 
TG~ACTGTGTT  TA AA  TG  TTC  CTACCAAGT TACCCCTTTTTCCTCGCTTGT  ACTAT  CT  CTTAC  GTTA  C  AACGTAAA  CAATT  AA  C  CGCC  GTTAATAACCTCATATATG  AA  981 
TACAAGTG  CAAATGTACCTGTACAGACACCTATCAGCCATTGCAT•ACTTGAGTCTT•ACA•AATCAATCTGCATCTTCATATTGGTCACTTCTT•CTCAATTTT  1086 
1113  GGTGTCGATTTCTTTTATTTCCAGATC 
b 
I  II 
II  m  I 
S 
'  Fi~i~i~iiiiiiii[ 
-100  1 
i  L  J  L 
E  HE  S  S,  ,/ 
500  1000 
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cDNA 
FIGURE  2  Sequence of the SEC53 gene. (a) Primary  sequence of the SEC53 gene. (b) Sequencing strategy for SEC53. The solid 
bar represents the coding region, dotted areas the 5'  and 3'  non-coding regions from the SEC53 mRNA. Arrows above show 
sequencing strategy  for genomic DNA subcloned into M13; arrows  below  indicate sequences obtained from the cDNA clone. 
Numbers refer to the nudeotides relative to the initiating A of the coding sequence. Light boxes indicate TATA sequences; heavy 
box indicates a  poly A  addition signal; asterisk  is first nucleotide found in the cDNA; poly A  indicates site of poly A addition 
found in the cDNA; underlined sequences correspond to the restriction  sites indicated. 
hybridization to be present at 15-30 copies per cell (data not 
shown). 
Overproduction of the 28-kD protein was further correlated 
with SEC53 by analysis of Tn5 transposon insertion muta- 
tions introduced into pSEC5310. Four insertions were evalu- 
ated, two of which inactivated SEC53 complementing activity 
by disruption or deletion.  The 28-kD protein was overpro- 
duced  only  in  the  two  transformants that  contained  Tn5 
insertions outside of SEC53 (Fig.  4,  lanes B  and D).  These 
data suggest that the 28-kD protein is the product of SEC53, 
or of another protein whose expression is regulated by SEC53 
gene dosage. 
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A  more direct connection between the 28-kD protein and 
SEC53  was  made  by  isolation  and  in  vitro  translation of 
SEC53  mRNA.  The 0.5-kb  BglII/HindIII  fragment,  which 
encompasses the 5' half of SEC53 (Fig. l B, fragment C), was 
subcloned  into  the  E.  coli  vector  pUC9  (pSEC5316). 
pSEC5316  was  used  to hybrid  select SEC53  mRNA  from 
total yeast RNA, followed by translation of the purified mes- 
sage in a rabbit reticulocyte protein synthesis system. Radio- 
active  protein  products  from  hybrid-selected  and  control 
translation reactions were compared by SDS gel electropho- 
resis and autoradiography. Fig.  5 (lane C) shows the product 
of the reaction was the 28-kD protein previously associated FIGURE 3  Overproduction of Sec53p. Yeast cells (strain MBY7-5C) 
containing different  plasmids  were  labeled with  35SO4 for  6  h. 
Whole cell extracts were subjected  to SDS PAGE on 121/2%  gels (3 
x  106 cpm/lane) followed by autoradiography. 
with SEC53. (The 43-kD protein observed in this experiment 
is an artifact of translation with a rabbit reticulocyte system 
in the presence of [35S]methionine.) 
Immune Detection and Localization of 5ec53p 
Having detected Sec53p, we developed an antibody probe 
suitable for identification of the protein in subcellular frac- 
tions. A portion of the SEC53 gene representing amino acids 
6 through  151  was fused to the 3'  end of the E.  coli LacZ 
gene. A hybrid protein product with the predicted size was 
produced in E. coli, and the exact nature of  the fusion  junction 
was confirmed by DNA  sequence analysis.  Because of the 
high level of expression of the hybrid in  E.  coli,  a  simple 
fractionation scheme, concluding with preparative SDS gel 
electrophoresis, was used for purification of the protein. A 
polyclonal serum directed against/3-galactosidase  and Sec53p 
epitopes was developed in response to immunization with the 
hybrid protein. 
Recognition of Sec53p by the antiserum was tested in two 
ways: decoration of the antigen in SDS gels of untransformed 
and pSEC5310-transformed yeast strains,  and immune pre- 
cipitation of hybrid-selected mRNA translation products. Fig. 
6 shows that at 240C, the 28-kD protein was detected in both 
mutant and wild-type cells, and that similar levels of overpro- 
duction  (eightfold)  were  achieved  by  introduction  of 
pSEC5310. At 37°C, the level of Sec53p in sec53-6 cells is 
diminished relative to wild-type, indicating a lability expected 
of a denatured polypeptide (data not shown). Immune precip- 
itation of Sec53p was performed on the translation product 
ofSEC53 mRNA enriched by hybrid selection shown in Fig. 
5 (lane C). This protein was precipitated by Sec53p antiserum 
(lane D),  while preimmune serum  did  not  react (lane E). 
FIGURE 4  Effect of Tn5 insertions in pSEC5310. Yeast cells (strain 
MBY7-5C) containing plasmid  pSEC5310 with different Tn5 inser- 
tions were labeled with 3sso4 for 6  h. Whole cell extracts were 
subjected to SDS PAGE on 121/2%  gels (3 x  106 cpm/lane) followed 
by autoradiography.  SEC53 heading  indicates the ability of a plasmid 
to complement a sec53 mutation. Tn5 insertions in pSEC5310 were 
found for Tn5-16, in the 400-bp EcoRl fragment of the 5EC53 coding 
region; Tn5-20,  in the 50-bp Pstl-EcoRl fragment of yeast DNA 3' 
to 5EC53; Tn5-22, in 5EC53 (also  deletes the 3' half of 5EC53); Tn5- 
24, in the LEU2 region of pSEC5310; YEp13, control plasmid. 
Parallel evaluation of the in  vitro translation product and 
immune decorated cell lysates showed coincident migration 
of Sec53p on SDS PAGE (not shown). 
Sec53p in the Cytosol Fraction 
Yeast cells were fractionated to determine if Sec53p was 
localized in the cytosolic or microsomal fractions. Fractiona- 
tion  was  performed with  secl8  mutant  cells incubated  at 
permissive (24°C) and restrictive (37°C) temperatures under 
conditions which derepressed synthesis of the  secreted en- 
zyme, invertase. In this mutant, protein transport from the 
ER  is  blocked and  soluble  forms of invertase accumulate 
within the ER lumen (15). Although the lumenal contents are 
easily  released  from  secl8  ER  membranes,  conditions  of 
spheroplast lysis have been developed that retain this structure 
in an intact, sedimentable form (15).  Such conditions were 
used to establish the location of Sec53p. 
Cells  were converted to spberoplasts,  lysed,  and aliquots 
centrifuged at 100,000 g for 1 h. Samples of the extract, high 
speed supernatant, and high speed pellet fractions were eval- 
uated by SDS gel electrophoresis  and immunodecoration with 
Sec53p and invertase antibodies. Fig. 7a shows the distribu- 
tion of Coomassie Blue staining protein species in the three 
fractions prepared from secl8 cells incubated at the restrictive 
and permissive temperatures. Fig. 7 b shows that most of the 
Sec53p was in the high speed supernatant fraction prepared 
from cells incubated at either temperature. The same distri- 
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cipitation of Sec53p. Plasmid pSEC5316 (lanes C-E) or pUC9 (lanes 
B and F) were used to hybrid select total yeast RNA for translation 
in vitro. Translation  products  were untreated (lanes A-C), treated 
with immune IgG (lanes D and F), or treated with preimmune serum 
(lane E), and  subjected  to SDS PAGE on  121/2%  gels followed by 
fluorography. Lane A  contains  the translation  products  obtained 
from 10 p.g of total yeast RNA. 
bution of Sec53p was found in fractions from wild-type cells 
(not shown). A small amount of two higher mobility species 
was found in the high speed supernatant and high speed pellet 
fractions.  These  may  represent  proteolytic  fragments  of 
Sec53p;  they  were  less  apparent  in  samples  of the  crude 
extract. Fig.  7 c shows the distribution of invertase immuno- 
reactive forms. Extracts of cells incubated at 37"C show the 
ER-accumulated transit form of invertase exclusively in the 
high  speed  pellet  fraction.  This  form was too  transient  to 
detect in cells incubated at 24"C.  An alternate transcript of 
the invertase gene (SUC2) gives rise to a cytoplasmic form of 
the enzyme (37) which appeared in the high speed supernatant 
fraction in both cell samples. 
Densitometric scanning of immunoblots performed with 
varying levels of antigen was used to quantify the fractiona- 
Lion. These values are compiled in Table II along with the 
recovery and enrichment of known markers of the ER mem- 
brane (NADPH cytochrome c reductase) and cytosol (glycer- 
aldehyde-3-phosphate dehydrogenase). On the basis of these 
data we conclude that Sec53p is a cytosolic protein, though it 
could be detached from the cytoplasmic surface of a  mem- 
brane by our method of cell lysis. 
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FIGURE 6  Steady state levels of Sec53p. Cell extracts from strains 
MBY7-5C  (sec53) and JRY9 (5EC53) containing different plasmids 
were subjected  to SDS PAGE on 121/2% gels (40/~g protein/lane). 
Proteins were transferred  to nitrocellulose and probed with anti- 
Sec53p IgG diluted 1:50  and 1251-protein  A followed by autoradiog- 
raphy. 
DISCUSSION 
The SEC53 gene has been cloned from yeast genomic and 
cDNA expression libraries. A  single  insert that integrates at 
the sec53 locus contains an open reading frame that predicts 
a 29-kD protein. Part of the cloned gene was used in a gene 
disruption protocol to show that SEC53 is essential for ger- 
mination  of yeast spores.  Although  the  essential  nature  of 
SEC53 is implied by the conditionally lethal alleles described 
previously (3), this phenotype could be explained by a  null 
allele of sec53 replaced in a temperature-sensitive fashion by 
another protein. Such cases have been reported for other yeast 
genes (38).  The gene disruption  results show that SEC53  is 
required directly. 
A protein of ~28-kD, as predicted from the DNA sequence, 
is overproduced by cells that contain SEC53 on a multicopy 
plasmid.  Additional  evidence  identifying  this  protein  as 
Sec53p has come from transponson mutagenesis of plasmid 
DNA, from hybrid selection of mRNA and translation in a 
reticulocyte reaction,  and  from production  of antibody di- 
rected against a portion of the SEC53 coding sequence. 
These techniques have been used to monitor the level and 
cellular location of Sec53p. In rich medium, SEC53 mRNA 
is  present  in  15  to  30  copies  per  cell  which  accounts  for 
expression of the protein at a high level. At 24"C, the steady 
state level of Sec53p is not affected by the sec53-6 mutation FIGURE  7  Fractionation  of secl8  cells,  sec18 ceils  incubated  at  37"C  or  24°C  were fractionated  and  Extract  (E), 100,000-g 
supernatant (HSS), and lO0,O00-g pellet (HSP) fractions were subjected to SDS PAGE  (40/~g protein/lane). (a) Coomassie Blue- 
stained gel (121/2% gel). (b) Autoradiogram of immunoblot using anti-Sec53p IgG diluted  1:50 (121/2% gel). (c) Autoradiogram of 
immunoblot using anti-invertase antibody diluted 1:400 (71/2% gel). 
TABLE II.  Recovery* (and Enrichment*)  in Fractions of secl8 Cells 
Cytoplasmic  NADPH  Cyto- 
Sec53p  invertase  ER invertase  GAP  chrome c reductase 
37°C 
Extract  100 (I .0)  100 (I .0)  100 (I .0)  100 (I .0)  100 (1.0) 
HSS  98 (2.2)  144 (3.2)  5 (0.1 I)  70 (1.6)  4 (0.09) 
HSP  11  (0.24)  5 (0.12)  57 (1.2)  3 (0.06)  64 (1.4) 
24°C 
Extract  100 (1.0)  100 (1.0)  NA  100 (1.0)  100 (1.0) 
HSS  77 (2.6)  78 (2.6)  NA  59 (2.0)  4 (0.11) 
HSP  4 (0.11)  6 (0.18)  NA  3 (0.06)  62 (1.7) 
Secl8 ceils were fractionated as described in the legend to Fig. 7. Levels of sec53p, cytoplasmic invertase, and ER-accumulated invertase in each fraction 
were determined by quantitative  immunoblotting and densitometry  of autoradiograms. Levels of glyceraldehyde-3-phosphate dehydrogenase (GAP) and 
NADPH cytochrome c reductase were determined by enzymatic assays. 
* Recovery is percent of activity found in Extract. 
Enrichment, shown in parentheses, is specific activity in each fraction. 
NA, not applicable. 
nor by changes  in  growth  medium  that  cause derepressed 
synthesis of invertase. At 37"C, however, the mutant protein 
is labile. An eightfold overproduction of Sec53p is obtained 
in  cells transformed with  a  multicopy plasmid that carries 
SEC53. Overproduction at this level has no harmful effect on 
protein  secretion  or cell growth.  Under the  conditions  ex- 
plored here, expression of SEC53 appears to be constitutive 
and is not limited by the availability of regulatory factors. 
DNA sequence analysis has shown Sec53p to be a  hydro- 
philic protein with 30% charged amino acids and no signifi- 
cant length of hydrophobic peptide such as would be found 
in  a  membrane anchor  segment.  In  addition  to  no  signal 
peptide-like sequence, other forms of proteolytic maturation 
of Sec53p are unlikely. The primary translation product made 
in vitro and the mature polypeptide detected in cells are the 
same size and are consistent with the size calculated from the 
coding sequence. These characteristics are compatible with a 
cytosolic location of Sec53p. 
Direct evidence for a cytosolic location of Sec53p has come 
from evaluation of cell fractions with an antibody directed 
against part of the SEC53 coding sequence. Hence, models 
that rely on an integral membrane association or ER lumenal 
location of Sec53p are eliminated. 
The function  of Sec53p in translocation remains elusive. 
Our previous suggestion that Sec53p plays a direct role in this 
process came from the observation that invertase accumulated 
in see53 at 37"C was exposed on the cytoplasmic surface of 
the  ER  membrane  and  was  largely  susceptible  to  trypsin 
digestion (4).  In this orientation, cytosolic Sec53p could act 
directly on the secretory polypeptide during the translocation 
event.  We  have  recently  found,  however,  that  alternative 
conditions of see53 membrane isolation and trypsin treatment 
preserve an apparently complete form of invertase (Feldman, 
R., and R. Schekman, unpublished results).  These new data 
suggest  that secretory molecules may accumulate on the lu- 
menal surface of the ER membrane when the see53 block is 
imposed. In this circumstance, Sec53p would act indirectly to 
allow folding and glycosylation of secretory precursors within 
the ER lumen. Moreover, as the see53 block is thermorever- 
sible,  mutant Sec53p function must be restored in the cyto- 
plasm in a fashion that allows interrupted assembly to com- 
mence on the other side of the ER membrane. Sec53p may 
execute its function by producing a small molecule required 
for protein assembly in the ER lumen, or by influencing the 
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It seems unlikely that defective oligosaccharide synthesis or 
transfer can account directly for the effect of see53 on protein 
assembly in the ER. First,  unlike Sec53p, all the enzymes of 
oligosaccharide biosynthesis and transfer to protein are inte- 
gral membrane proteins (39,  40).  Second, alleles of SEC53, 
identified  as  deficient  in  asparagine-linked  glycosylation 
(alg4),  show a  spectrum of dolichol-oligosaccharides (from 
man, to marts) accumulated at the restrictive temperature in 
vivo and in vitro (41; also K. Runge and P. Robbins, personal 
communication). At  least some of the smaller oligosaccha- 
rides may be transferred to protein at 37"C because invertase 
accumulated in see53 has a  slightly reduced electrophoretic 
mobility which is not increased by treatment with endogly- 
cosidase H. Oligosaccharides smaller than MansGlcNAc are 
resistant to cleavage by endoglycosidase H. That any of the 
oligosaccharide precursors are produced in the mutant argues 
that the sugar-nucleofides UDP-GlcNAc  and GDP-man are 
available  for  glycosylation.  Finally,  the  vanadate-sensitive 
plasma membrane ATPase, another molecule whose assembly 
is blocked in sec53, appears not to be glycosylated at any state 
in its biosynthesis (Hansen, W., and R.  Schekman, unpub- 
lished  results).  Hence,  though  Sec53p  appears to  influence 
oligosaccharide synthesis, this in itself cannot account for the 
role it plays in protein assembly. 
Glutathione is another small molecule that could play a 
role in proper assembly in the ER.  Scheele and Jacoby (42) 
showed that oxidized glutathione stimulates proper disulfide 
bond  formation and protein folding  in  an in  vitro protein 
synthesis reaction coupled to protein translocation into dog 
pancreas microsomal vesicles. If the generation of oxidized 
glutathione is deficient in see53, the defect is unlikely to be 
directly related to translocation because the a-factor precursor 
molecule, whose assembly is blocked in see53 mutant cells 
(43), contains no cysteine residues. 
Many other indirect influences on ER membrane structure 
can be invoked to explain the see53 phenotype. For example, 
although  the  major  phospholipids  are  made  in  normal 
amounts in see53 (S. Henry, personal communication), their 
intracellular distribution could be altered to the detriment of 
ER assembly processes. Models such as this are constrained 
by the observation that assembly of mitochondrial membrane 
and matrix proteins are not delayed in sec53 at 37"C (R. Hay 
and G. Schatz, personal communication). 
Now that Sec53p has been located in the cytosol, it should 
be possible to detect restoration of some aspect of secretory 
protein  assembly  in  mixtures  containing  see53  membrane 
and wild-type cytosol fractions. 
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